» Articles » PMID: 25443037

HIV Testing and Counselling in Estonian Prisons, 2012 to 2013: Aims, Processes and Impacts

Overview
Journal Euro Surveill
Date 2014 Dec 3
PMID 25443037
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

We present data from an observational cohort study on human immunodeficiency virus (HIV) prevention and control measures in prisons in Estonia to assess the potential for HIV transmission in this setting. HIV testing and retesting data from the Estonian prison health department were used to estimate HIV prevalence and incidence in prison. Since 2002, voluntary HIV counselling and testing has routinely been offered to all prisoners and has been part of the new prisoners health check. At the end of 2012, there were 3,289 prisoners in Estonia, including 170 women: 28.5% were drug users and 15.6% were infected with HIV. Of the HIV-positive inmates, 8.3% were newly diagnosed on prison entry. In 2012, 4,387 HIV tests (including retests) were performed in Estonian prisons. Among 1,756 initially HIV-negative prisoners who were in prison for more than one year and therefore tested for HIV twice within 12 months (at entry and annual testing), one new HIV infection was detected, an incidence of 0.067 per 100 person-years (95% confidence interval (CI): 0.025–5.572). This analysis indicates low risk of HIV transmission in Estonian prisons. Implementation of HIV management interventions could impact positively on the health of prisoners and the communities to which they return.

Citing Articles

HIV seroprevalence in five key populations in Europe: a systematic literature review, 2009 to 2019.

Stengaard A, Combs L, Supervie V, Croxford S, Desai S, Sullivan A Euro Surveill. 2021; 26(47).

PMID: 34823636 PMC: 8619876. DOI: 10.2807/1560-7917.ES.2021.26.47.2100044.


Missed opportunities for HIV testing in people diagnosed with HIV, Estonia, 2014 to 2015.

Ruutel K, Lemsalu L, Latt S, Epstein J Euro Surveill. 2019; 24(15).

PMID: 30994106 PMC: 6470370. DOI: 10.2807/1560-7917.ES.2019.24.15.1800382.


Hepatitis C seropositivity among newly incarcerated prisoners in Estonia: data analysis of electronic health records from 2014 to 2015.

Kivimets K, Uuskula A, Lazarus J, Ott K BMC Infect Dis. 2018; 18(1):339.

PMID: 30031373 PMC: 6054745. DOI: 10.1186/s12879-018-3242-2.


Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area.

Tavoschi L, Vroling H, Madeddu G, Babudieri S, Monarca R, Vonk Noordegraaf-Schouten M Epidemiol Rev. 2018; 40(1):105-120.

PMID: 29648594 PMC: 5982719. DOI: 10.1093/epirev/mxy001.


The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.

Altice F, Azbel L, Stone J, Brooks-Pollock E, Smyrnov P, Dvoriak S Lancet. 2016; 388(10050):1228-48.

PMID: 27427455 PMC: 5087988. DOI: 10.1016/S0140-6736(16)30856-X.